Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
- 30 August 2010
- journal article
- Published by Wiley in Hepatology Research
- Vol. 40 (9) , 870-877
Abstract
Aim: Hepatic steatosis is linked to development of hepatocellular carcinoma (HCC) in non‐viral liver disease such as non‐alcoholic steatohepatitis. The present study aimed to assess whether hepatic steatosis is associated with the development of HCC in chronic hepatitis C.Methods: We studied a retrospective cohort of 1279 patients with chronic hepatitis C who received interferon (IFN) therapy between 1994 and 2005 at a single regional hospital in Japan. Of these patients, 393 had a sustained virological response (SVR) and 886 had non‐SVR to IFN therapy. After IFN therapy, these patients were screened for development of HCC every 6 months. The average period of observation was 4.5 years.Results: HCC developed in 68 patients. The annual incidence of HCC was 2.73% for patients with a steatosis grade of 10% or greater and 0.69% for patients with a steatosis grade of 0–9%. On multivariate analysis, higher grade of steatosis was a significant risk factor for HCC independent of older age, male sex, higher body mass index (BMI), advanced fibrosis stage and non‐SVR to IFN therapy. The adjusted risk ratio of hepatic steatosis was 3.04 (confidence interval 1.82–5.06, P < 0.0001), which was higher than that of older age (1.09), male sex (2.12), non‐SVR to IFN (2.43) and higher BMI (1.69).Conclusion: Hepatic steatosis is a significant risk factor for development of HCC in chronic hepatitis C independent of other known risk factors, which suggest the possibility that amelioration of hepatic steatosis may prevent hepatocarcinogenesis.Keywords
This publication has 31 references indexed in Scilit:
- Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2βHepatology, 2008
- Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosisCancer, 2007
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Impact of steatosis on progression of fibrosis in patients with mild hepatitis CHepatology, 2004
- Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infectionCancer, 2003
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United StatesHepatology, 2002
- NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United StatesHepatology, 2002
- Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis CGut, 2002
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996